- Home
- Companies
- usa rhode island
- pre operational
Refine by
Pre Operational Suppliers Serving Usa Rhode Island
4 companies found
Technologybased inScottsdale, ARIZONA (USA)
Tesis Biosciences’ unique integrated medical platform is revolutionizing targeted genetic sequencing. Our mission is to change medicine by providing physicians, hospitals, and researchers with the tools to help patients treat and overcome major ...
Orthopedic Wound NGS is a comprehensive wound pathogen panel provided by Tesis Biosciences. One simple swab collection provides fast, definitive identification of targeted ...
Technologybased inAliso Viejo, CALIFORNIA (USA)
OrthAlign is the leader in simple, smart technology for joint surgery; powering partial knee, total knee, and total hip replacements using any approach. Using advanced microelectrome chanical sensors, our solutions deliver clinically proven ...
When all non-invasive treatment has been exhausted and/or the damage is extensive, Total Knee Replacement (TKR) is one of the most successful of all surgical procedures, with a 90-95% success rate for pain relief.11 It involves replacing the bones ...
Technologybased inBaltimore, MARYLAND (USA)
Clear Guide Medical is a privately-held company headquartered in Baltimore, Maryland, and is a spinout of the Johns Hopkins Medical Institutions and The Johns Hopkins University. The company is offering ongoing investment opportunities to support ...
Sterile on-patient markers enable automatic registration between imaging modalities and provide constant updating of registration. Automatic registration takes less than 10 seconds and lasts throughout the ...
Technologybased inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for ...